Mice treated with AAV9‐TRF1 at 1 and at 2 years of age showed a tendency to show lower cancer incidence compared to the empty‐vector‐treated mice, although the differences did not reach significance (Fig. 5A,B). The gene discussed is TERF1; the disease is cancer.